Standards; Steroids; Pharmaceutical/API Drug Impurities/Metabolites;
應用:
3,5-cyclo-Abiraterone is derived from Abiraterone (A108490), which is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
?您的位置：
